Alzheimer´s Disease (AD) is a neurodegenerative disorder which represents a problem for the public health system because it affects more than 50 million people in the world, currently there is no successful treatment to treat this disease. The most accepted hypothesis regarding the development of this disease is the accumulation of plaques Aβ in the brain, have studied different molecules of natural origin as treatment based on this hypothesis. Cannabis sativa L. is a plant that has great potential as a treatment for this disease due to its antioxidant and neuroprotective properties and it has been shown to reduce the accumulation of Aβ plaques.
Previous Article in event Previous Article in congress
Next Article in event Next Article in congress
Use of Cannabis sativa L. for the treatment of Alzheimer's disease
Published: 04 July 2019 by MDPI in MOL2NET'19, Conference on Molecular, Biomedical & Computational Sciences and Engineering, 5th ed. congress USINEWS-03: US-IN-EU Worldwide Science Workshop Series, UMN, Duluth, USA, 2019
Keywords: Alzheimer´s disease, Cannabis, Neuroprotection